Prosecution Insights
Last updated: October 02, 2026

Rambam Health Corporation

Technology area: Transportation, E-Commerce & Mechanical Systems

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Rambam Health Corporation manages a company patent portfolio in the Transportation, E-Commerce & Mechanical Systems technology area. The portfolio currently features 1 pending office action. This action is being reviewed by 1 distinct examiner, AKOGYERAM II, NICHOLAS A, within 1 distinct art unit.

The busiest examiner, AKOGYERAM II, NICHOLAS A, is responsible for 1 busiest examiner pending office action. Since there is only 1 pending office action in the portfolio, this examiner is the only 1 currently active on the company's cases. The use of 1 distinct art unit indicates that the Transportation, E-Commerce & Mechanical Systems filings are currently confined to 1 specialized group.

Practitioners should recognize that with 1 pending office action and 1 distinct examiner, the prosecution process is highly focused. AKOGYERAM II, NICHOLAS A is the sole point of contact at the USPTO for the current pending matters. The focus within 1 distinct art unit means that the practitioner only needs to navigate the specific guidelines of that 1 unit. This allows for a very efficient and direct approach to the 1 pending office action.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
AKOGYERAM II, NICHOLAS A 1 26.7% +29.5%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18947247 METHOD DEVICE AND SYSTEM FOR MONITORING SUB-CLINCAL PROGRESSION AND REGRESSION OF HEART FAILURE AKOGYERAM II, NICHOLAS A 30d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18947247 METHOD DEVICE AND SYSTEM FOR MONITORING SUB-CLINCAL PROGRESSION AND REGRESSION OF HEART FAILURE AKOGYERAM II, NICHOLAS A 30d overdue

Top Art Units

Art UnitApps
3686 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18947247 METHOD DEVICE AND SYSTEM FOR MONITORING SUB-CLINCAL PROGRESSION AND REGRESSION OF HEART FAILURE AKOGYERAM II, NICHOLAS A 3686 §101§112 Non-Final OA 30d overdue Pending Nov 14, 2024

Managing Rambam Health Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month